New heart monitor algorithm put to the test

NCT ID NCT06172699

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well a new heart monitor (Assert-IQ) detects atrial fibrillation (an irregular heartbeat) in people who have had a heart ablation procedure. 151 participants wore the monitor as part of their normal care. Researchers compared the monitor's readings to a standard Holter monitor to see how accurate the new device's detection algorithm is.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aurora Medical Group

    Milwaukee, Wisconsin, 53215, United States

  • Erlanger Medical Center

    Chattanooga, Tennessee, 37403, United States

  • Heart Rhythm Associates

    The Woodlands, Texas, 77380, United States

  • Kansas City Cardiac Arrhythmia Research Foundation

    Overland Park, Kansas, 66211, United States

  • Methodist Texsan Hospital

    San Antonio, Texas, 78201, United States

  • Orlando Health

    Orlando, Florida, 32806, United States

  • Shannon Clinic

    San Angelo, Texas, 76903, United States

  • St. Peter's Health Partners Medical Associates, PC

    Albany, New York, 12205, United States

  • Trident Medical Center

    Charleston, South Carolina, 29406, United States

  • Trinity Health-Michigan d/b/a Michigan Heart

    Ann Arbor, Michigan, 48106, United States

  • University of California at San Diego (UCSD) Medical Center

    San Diego, California, 92103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.